Lv4
512 积分 2025-01-12 加入
A Phase 1, Open‐Label, Single Ascending (Two Levels) Dose Study to Evaluate the Pharmacokinetics of Vorasidenib in Healthy Japanese and Non‐Asian Participants
4天前
已完结
Concentration‐QTc Analysis as an Alternative to TQT Studies: Findings From QT Evaluation and Safety Labeling Decisions in Japan
4天前
已完结
Clinical pharmacokinetics of bevacizumab in patients with solid tumors
18天前
已完结
Learnings from Approved Antibody‐Drug Conjugates: Clinical Pharmacology Perspectives
24天前
已完结
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
24天前
已完结
Exposure-Response Relationships of Antibody Drug Conjugates in Solid Tumours
1个月前
已关闭
Bystander effect in antibody-drug conjugates: Navigating the fine line in tumor heterogeneity
1个月前
已完结
Plasma Pharmacokinetics of the Lactone and Carboxylate Forms of 20(S)-Camptothecin in Anesthetized Rats
1个月前
已完结
Review of dose justifications for antibody-drug conjugate approvals from clinical pharmacology perspective: A focus on exposure-response analyses
1个月前
已完结
Review of dose justifications for antibody-drug conjugate approvals from clinical pharmacology perspective: A focus on exposure-response analyses
1个月前
已完结
皖公网安备34019202002308
